Compound Q&A
What is the market or research trend for Tubeimoside III (CAS: 115810-13-4)?
Answer
Tubeimoside III (CAS: 115810-13-4) has gained interest in recent research due to its potential biological activities, particularly in cancer therapy. Market trends indicate increasing demand for its use in pharmaceutical and biotechnology applications. Research is focusing on understanding its mechanism of action, optimizing synthesis techniques, and exploring its therapeutic potential. The trend suggests a growing focus on natural products and their derivatives in drug development.
About
CAS No
115810-13-4
English Name
Tubeimoside III
Molecular Formula
C64H100O31
Molecular Weight
1365.5 g/mol
SMILES
CC1C2C(C(C(O1)OC3C(C(COC3OC(=O)C45CCC(CC4C6=CCC7C(C6(CC5O)C)(CCC8C7(CC(C(C8(C)CO)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)COC(=O)CC(CC(=O)O2)(C)O)O)O)O)O)C)C)(C)C)O)O)O)OC1C(C(C(CO1)O)O)O
InChIKey
MTICHQXHYUJVDV-UHFFFAOYSA-N
Last Updated: 2025-10-08 13:11
